SPINRAZA 12MG/5ML INJECTION
|Pack size||5 ml single dose vial|
|Treatment||Spinal Muscular Atrophy|
|Packaging Size||12 mg/5 ml vial|
Nusinersen (INN), marketed as Spinraza, is a drug used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder. Nusinersen has orphan drugdesignation in the United States and the European Union.